These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 22511499)

  • 1. Lost in translation? IL28B's discovery and the journey back to the patient.
    Clark PJ; Muir AJ
    Hepatology; 2012 Jul; 56(1):5-8. PubMed ID: 22511499
    [No Abstract]   [Full Text] [Related]  

  • 2. Introduction to the genetics and biology of interleukin-28B.
    Urban T; Charlton MR; Goldstein DB
    Hepatology; 2012 Jul; 56(1):361-6. PubMed ID: 22511448
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical utility of interleukin-28B testing in patients with genotype 1.
    Lai M; Afdhal NH
    Hepatology; 2012 Jul; 56(1):367-72. PubMed ID: 22511388
    [No Abstract]   [Full Text] [Related]  

  • 4. Association between IL28B polymorphism and treatment response in patients with genotype 4 chronic hepatitis C.
    Stättermayer AF; Hofer H; Ferenci P
    J Hepatol; 2012 Sep; 57(3):706; author reply 706-7. PubMed ID: 22748774
    [No Abstract]   [Full Text] [Related]  

  • 5. Association between IL28B polymorphisms and first-phase viral load decrease in chronic hepatitis C virus-infected patients treated with peginterferon alfa-2b/ribavirin.
    Arends JE; Fransen JH; Hoepelman AI; van Baarle D
    Int J Antimicrob Agents; 2011 Dec; 38(6):538-9. PubMed ID: 21974859
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Will IL28B polymorphism remain relevant in the era of direct-acting antiviral agents for hepatitis C virus?
    Thompson AJ; McHutchison JG
    Hepatology; 2012 Jul; 56(1):373-81. PubMed ID: 22511355
    [No Abstract]   [Full Text] [Related]  

  • 7. IL28B rs12979860 C/T polymorphism in elderly chronic hepatitis C patients treated with pegylated-interferon and ribavirin.
    Giannini EG; Marenco S; Baldissarro I; Fazio V
    Aliment Pharmacol Ther; 2011 Aug; 34(3):398-400. PubMed ID: 21726252
    [No Abstract]   [Full Text] [Related]  

  • 8. Enhancing predictive ability of IL28B-SNPs for SVR in HCV.
    Amanzada A; Schneider S; Moriconi F; Mihm S; van Thiel DH; Ramadori G
    Aliment Pharmacol Ther; 2012 Jan; 35(2):317-8. PubMed ID: 22172087
    [No Abstract]   [Full Text] [Related]  

  • 9. IL28B polymorphisms and chronic hepatitis C.
    Chevaliez S; Hézode C
    Gastroenterol Clin Biol; 2010 Nov; 34(11):587-9. PubMed ID: 20889274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the frequency of the IL-28 polymorphism (rs8099917) in patients with chronic hepatitis C using Zip nucleic acid probes, Kerman, Southeast of Iran.
    Iranmanesh Z; Mollaie HR; Arabzadeh SA; Zahedi MJ; Fazlalipour M; Ebrahimi S
    Asian Pac J Cancer Prev; 2015; 16(5):1919-24. PubMed ID: 25773845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IL28B polymorphism is associated with treatment response in patients with genotype 4 chronic hepatitis C.
    Asselah T; De Muynck S; Broët P; Masliah-Planchon J; Blanluet M; Bièche I; Lapalus M; Martinot-Peignoux M; Lada O; Estrabaud E; Zhang Q; El Ray A; Vidaud D; Ripault MP; Boyer N; Bedossa P; Valla D; Vidaud M; Marcellin P
    J Hepatol; 2012 Mar; 56(3):527-32. PubMed ID: 21951981
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-dose (peg)interferon therapy in treatment-naïve, interleukin-28B rs12979860 CT/TT genotype 1 chronic hepatitis C.
    Orlent H; Hansen B; Janssen HL; De Knegt RJ
    Dig Liver Dis; 2015 Jan; 47(1):87-8. PubMed ID: 25308611
    [No Abstract]   [Full Text] [Related]  

  • 13. Association between IL28B gene polymorphisms and sustained virological response in patients coinfected with HCV and HIV in Brazil.
    Ferreira PR; Santos C; Côrtes R; Reis A; Tenore Sde B; Silva MH; Vilhena C; Diaz RS
    J Antimicrob Chemother; 2012 Feb; 67(2):509-10. PubMed ID: 22146876
    [No Abstract]   [Full Text] [Related]  

  • 14. Prediction of response to peginterferon-alfa-2b plus ribavirin therapy in Japanese patients infected with hepatitis C virus genotype 1b.
    Hashimoto Y; Ochi H; Abe H; Hayashida Y; Tsuge M; Mitsui F; Hiraga N; Imamura M; Takahashi S; Nelson Hayes C; Ohishi W; Kubo M; Tsunoda T; Kamatani N; Nakamura Y; Chayama K
    J Med Virol; 2011 Jun; 83(6):981-8. PubMed ID: 21503910
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IL28B: A new wager in the skyline of hepatitis C virus infection.
    Mangia A
    Dig Liver Dis; 2011 Mar; 43(3):177-9. PubMed ID: 21237729
    [No Abstract]   [Full Text] [Related]  

  • 16. Boceprevir.
    Maddur H; Kwo PY
    Hepatology; 2011 Dec; 54(6):2254-7. PubMed ID: 22095684
    [No Abstract]   [Full Text] [Related]  

  • 17. Prevalence of
    Świątek-Kościelna B; Kałużna E; Strauss E; Nowak J; Bereszyńska I; Gowin E; Wysocki J; Rembowska J; Barcińska D; Mozer-Lisewska I; Januszkiewicz-Lewandowska D
    World J Gastroenterol; 2017 Jun; 23(21):3815-3824. PubMed ID: 28638221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High frequencies of a favorable IL-28B rs8099917 polymorphism and the clinical implications in patients with HCV in one multiracial area of Taiwan.
    Cheng CH; Lin CC; Chen HL; Lin IT; Wu CH; Lee YK; Wong MW; Bair MJ
    Kaohsiung J Med Sci; 2017 Oct; 33(10):510-515. PubMed ID: 28962822
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Effects of IL-28B and ITPA polymorphisms on treatment of hepatitis C virus genotype 6.
    Seto WK; Tanaka Y; Liu K; Lai CL; Yuen MF
    Am J Gastroenterol; 2011 May; 106(5):1007-8. PubMed ID: 21540909
    [No Abstract]   [Full Text] [Related]  

  • 20. IL28B polymorphisms do not predict response to therapy in chronic hepatitis C with HCV genotype 5.
    Antaki N; Bibert S; Kebbewar K; Asaad F; Baroudi O; Alideeb S; Hadad M; Abboud D; Sabah H; Bochud PY; Negro F
    Gut; 2012 Nov; 61(11):1640-1. PubMed ID: 22345656
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.